VANGUARD GROUP INC

Holdings History for Xilio Therapeutics, Inc. - Common Stock, par value $0.0001 per share (XLO)

Symbol: XLO on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	0%	$803,643	1,255,692	0		$0.64	Q4 2025
30 Sep 2025	0%	+0%	$1,058,549	1,255,692	+104,669	+9.1%	$0.84	Q3 2025
30 Jun 2025	0%	0%	$782,696	1,151,023	+15,307	+1.3%	$0.68	Q2 2025
31 Mar 2025	0%	+0%	$822,258	1,135,716	+233,185		$0.72	Q1 2025
31 Dec 2024	0%	0%	$861,918	902,531	0		$0.96	Q4 2024
30 Sep 2024	0%	0%	$711,195	902,531	0		$0.79	Q3 2024
30 Jun 2024	0%	0%	$855,148	902,531	0		$0.95	Q2 2024
31 Mar 2024	0%	0%	$974,734	902,531	0		$1.08	Q1 2024
31 Dec 2023	0%	0%	$496,392	902,531	+12,178	+1.4%	$0.55	Q4 2023
30 Sep 2023	0%	0%	$1,878,645	890,353	0		$2.11	Q3 2023
30 Jun 2023	0%	0%	$2,332,725	890,353	0		$2.62	Q2 2023
31 Mar 2023	0%	0%	$2,822,419	890,353	0		$3.17	Q1 2023
31 Dec 2022	0%	0%	$2,395,049	890,353	-1,180	-0.13%	$2.69	Q4 2022
30 Sep 2022	0%	+0%	$2,595,000	891,533	+472,368	+113%	$2.91	Q3 2022
30 Jun 2022	0%	0%	$1,224,000	419,165	+2,772	+0.67%	$2.92	Q2 2022
31 Mar 2022	0%	-0%	$2,944,000	416,393	-7,831	-1.8%	$7.07	Q1 2022
31 Dec 2021	0%	+0%	$6,788,000	424,224	+424,224	NEW	$16.00	Q4 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.